Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to billwilke's message
Running royalties would require a whole different level of "explicit technical detail" before the rates associated with each product could be calculated. This would necessarily require MUCH longer lead times in coming to meaningful conclusions about payment for past infringement and future running royalty payments. This IMO accounts for the new way and the delay in which royalties and past infringement payments will be received (or not rec'd YET in the current Q) and booked / recognized. It would require oversight by Judge Ward and would account for the shock of not seeing a giant number linked to the settlement and possibly some of the other licensees in the most recent Q. They waited too long and, now because of the settlement terms presumably specify running royalties and maybe the settlement sets a precedent and sets the bar higher and recent licensees are now maybe req'd to pay running royalties at the higher rates. JMO
Please login to post a reply
stillpoint21
City
Rank
Vice President
Activity Points
5182
Rating
Your Rating
Date Joined
05/19/2006
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post